Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Opinion | Anthropic’s Big IPO Gamble
The corporate says it might save humanity or destroy it. Buyers, place your bets. Source link
Kalshi down for some users during college football games
The Kalshi brand organized on a laptop computer in New York, US, on Monday, Feb. 10, 2025. Gabby Jones |…
SpaceX and Rivals Dodge Traffic as Satellites, Debris Crowd Low-Earth Orbit
The proliferation of synthetic materials circling the planet is elevating considerations over potential collisions. Source link